Analysis of malaria detection results among inbound population at Chengdu Port from 2024 to 2025

doi:10.12140/j.issn.1000-7423.2026.04.024

Abstract

Abstract:

Malaria surveillance data were collected from individuals entering China via Chengdu Port of Entry from 2024 to 2025, and the temporal, regional and population distributions of malaria were analyzed using a descriptive epidemiological method. A total of 11 144 traveler received malaria tests during the study period from 2024 to 2025, and the overall prevalence of malaria parasite infections was 1.55% (173/11 144). Among the confirmed infections, Plasmodium falciparum accounted for 94.22% (163/173), followed by P. malariae 3.68% (6/173), P. ovale 1.16% (2/173) and P. vivax 1.16% (2/173). The detection of malaria parasites was higher in 2025 (2.86%, 139/4 865) than in 2024 (0.54%, 34/6 279) (χ² = 96.78, P < 0.01). In terms of temporal distribution, the highest number of Plasmodium infections (87 cases, 50.29%) was reported during the period from October to December, followed by between July and September (56 cases, 32.37%). In terms of country of origin, most cases entered China from Ethiopia (87.86%, 152/173), followed by Qatar (5.20%, 9/173). In terms of case identification, most cases (70.52%, 122/173) were detected via on-site medical inspection, followed by high fever alerts (21.39%, 37/173). Of the 173 Plasmodium-positive cases, 166 were male (95.95%) and 7 were female (4.05%), with a male-to-female ratio of 23.71: 1. The majority of infected individuals were aged 31 to 60 years (85.55%, 148/173), with the largest number of cases detected at ages of 31 to 40 years (32.37%, 56/173). In terms of occupation, migrant labors constituted the largest proportion (89.02%, 154/173), followed by business (4.62%, 8/173). Among Plasmodium-positive individuals, 5 cases (14.70%, 5/34) in 2024 and 80 cases (57.55%, 80/139) in 2025 had a previous history of malaria. There were 71 cases (41.04%, 71/173) with fever upon entry. Laboratory screening under the multi-disease prevention strategy revealed 13 cases (7.51%, 13/173) co-infected with malaria and sexually transmitted diseases, and 29 cases (16.76%, 29/173) co-infected with respiratory infectious diseases. Malaria infections present distinct temporal, population and geographical characteristics among individuals entering China via Chengdu Port of Entry, and the risk of malaria infections rose markedly in 2025.

Key words: Malaria, Plasmodium, Imported, Chengdu Port

CLC Number:

R531.3

LI Mengqiu, LU Siyu, TIAN Lvbo, ZHANG Ningfeng, SHI Ying. Analysis of malaria detection results among inbound population at Chengdu Port from 2024 to 2025[J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2026, 44(4): 619-622.

Figures/Tables 2

References 18

[1]	王霞. 出境旅行要小心疟疾[J]. 人人健康, 2026(13): 88-89.
	Wang X. Be cautious of malaria when traveling abroad[J]. Health for Everyone, 2026(13): 88-89. (in Chinese)
[2]	杨硕, 夏尚, 闫书宁, 等. 基于国际贸易关系的我国输入性疟疾风险来源分析[J]. 中国寄生虫学与寄生虫病杂志, 2023, 41(6): 744-748, 755.
	Yang S, Xia S, Yan SN, et al. Analysis on the sources of imported malaria risk in China based on international trade relations[J]. Chin J Parasitol Parasit Dis, 2023, 41(6): 744-748, 755. (in Chinese)
[3]	高琪. 当前疟疾形势与我国消除疟疾后的再传播风险与对策[J]. 中国热带医学, 2024, 24(1): 1-5.
	Gao Q. Risk and countermeasures of re-establishment after malaria elimination in China[J]. China Trop Med, 2024, 24(1): 1-5. (in Chinese)
[4]	中华人民共和国国家卫生健康委员会疾病预防控制局. 中国顺利通过世界卫生组织消除疟疾认证[EB/OL]. (2021-06-30) [2025-07-28]. https://www.nhc.gov.cn/jkj/c100062/202106/62afe-3147ac847318ce920ecd31009ad.shtml.
	Bureau of Disease Control and Prevention, National Health Commission of the People’s Republic of China. China successfully passes the WHO certification for malaria elimination [EB/OL]. (2021-06-30) [2025-07-28]. https://www.nhc.gov.cn/jkj/c100062/202106/62afe3147ac847318ce920ecd31009ad.shtml.
[5]	Venkatesan P. The 2023 WHO world malaria report[J]. Lancet Microbe, 2024, 5(3): e214.
[6]	WHO. World malaria report 2024[R]. Geneva: World Health Organization, 2024.
[7]	杨婷婷. 浅析高铁经济对成都市城市发展的影响[J]. 山西农经, 2019(13): 33.
	Yang TT. Analysis on the impact of high-speed rail economy on urban development of Chengdu[J]. Shanxi Agric Econ, 2019(13): 33. (in Chinese)
[8]	张丽, 尹建海, 夏志贵. 中国防止疟疾输入再传播的成效与挑战分析[J]. 中国热带医学, 2024, 24(4): 365-371.
	Zhang L, Yin JH, Xia ZG. Analysis of effectiveness and challenges in preventing the re-establishment of malaria transmission in China[J]. China Trop Med, 2024, 24(4): 365-371. (in Chinese)
[9]	张丽, 夏志贵, 李石柱. 2024年全国疟疾疫情特征分析[J]. 中国寄生虫学与寄生虫病杂志, 2025, 43(2): 162-166.
	Zhang L, Xia ZG, Li SZ. Epidemiological characteristics of malaria in China, 2024[J]. Chin J Parasitol Parasit Dis, 2025, 43(2): 162-166. (in Chinese)
[10]	Ma XJ, Lu SN, Ding W, et al. Development of innovative tripartite partnership for China’s engagement in global health: recommendations from China-Tanzania cooperation project on malaria control[J]. Infect Dis Poverty, 2024, 13: 22.
[11]	Morris R, Wang SY. Building a pathway to One Health surveillance and response in Asian countries[J]. Sci One Heal, 2024, 3: 100067.
[12]	Sanna A, Suárez-Mutis M, Lambert Y, et al. Cooperation for malaria control and elimination in the Guiana Shield[J]. Lancet Glob Health, 2024, 12(5): e875-e881.
[13]	黄年霞, 梁海明, 刘丹, 等. 以海关视角探讨中国口岸输入性疟疾的防控[J]. 中国口岸科学技术, 2026, 8(4): 4-9.
	Huang NX, Liang HM, Liu D, et al. Discussion on the prevention and control of imported malaria at Chinese ports from the perspective of customs[J]. China Port Sci Technol, 2026, 8(4): 4-9. (in Chinese)
[14]	马赛, 胡薇, 王晓慧, 等. 多部门数据协同在输入性疟疾防控中的作用与优化建议[J]. 中国口岸科学技术, 2026, 8(4): 10-13.
	Ma S, Hu W, Wang XH, et al. The role and optimization suggestions of multi-department data collaboration in the prevention and control of imported malaria[J]. China Port Sci Technol, 2026, 8(4): 10-13. (in Chinese)
[15]	范志成, 夏咏, 陈猛, 等. 输入性恶性疟病例多次再燃发病调查分析[J]. 寄生虫病与感染性疾病, 2014, 12(3): 164-166.
	Fan ZC, Xia Y, Chen M, et al. Investigation and analysis of one imported case with repeatedly-relapsed malignant malaria[J]. Parasitoses Infect Dis, 2014, 12(3): 164-166. (in Chinese)
[16]	国家传染病医学中心撰写组. 疟疾诊疗指南[J]. 中国寄生虫学与寄生虫病杂志, 2022, 40(4): 419-427.
	Writing Group of National Center for Infectious Diseases. Guidelines for malaria diagnosis and treatment[J]. Chin J Parasitol Parasit Dis, 2022, 40(4): 419-427. (in Chinese)
[17]	倪敏君, 岑晨霞, 刘超群, 等. 我国疟疾输入再传播风险分析及应对举措[J]. 中国口岸科学技术, 2023, 5(4): 4-9.
	Ni MJ, Cen CX, Liu CQ, et al. Risk analysis and response measures of retransmission of imported malaria in China[J]. China Port Sci Technol, 2023, 5(4): 4-9. (in Chinese)
[18]	周耀武, 张丽, 夏志贵. 疟疾跨境输入与继发传播的风险及对策[J]. 中国血吸虫病防治杂志, 2025, 37(1): 14-18.
	Zhou YW, Zhang L, Xia ZG. Risk of and response to cross-border importation and secondary transmis-Sion of malaria[J]. Chin J Schisto Control, 2025, 37(1): 14-18. (in Chinese)

特征	疟原虫阳性人数				合计
特征	恶性疟原虫	卵形疟原虫	间日疟原虫	三日疟原虫	合计
性别
男	157	2	2	5	166
女	6	0	0	1	7
年龄
≤ 20	2	0	0	0	2
21~30	19	0	1	0	20
31~40	52	0	0	4	56
41~50	45	2	1	2	50
51~60	42	0	0	0	42
> 60	3	0	0	0	3
职业
经商	8	0	0	0	8
务工	147	1	1	5	154
学生	2	0	0	0	2
不详	5	1	1	1	8
无业	1	0	0	0	1